Hematology: percentage of patients aged 18 years and older with a diagnosis of myelodysplastic syndrome (MDS) who are receiving erythropoietin therapy with documentation of iron stores prior to initiating erythropoietin therapy.

TITLE
Hematology: percentage of patients aged 18 years and older with a diagnosis of myelodysplastic syndrome (MDS) who are receiving erythropoietin therapy with documentation of iron stores prior to initiating erythropoietin therapy.

SOURCE(S)
American Society of Hematology, Physician Consortium for Performance Improvement®. Hematology physician performance measurement set. Chicago (IL): American Medical Association (AMA); 2007 Jan. 22 p. [10 references]

abrir aquí para acceder al documento NQMC AHRQ completo:
Hematology: percentage of patients aged 18 years and older with a diagnosis of myelodysplastic syndrome (MDS) who are receiving erythropoietin therapy with documentation of iron stores prior to initiating erythropoietin therapy.